Subject
Pulmonary and Respiratory Medicine
Reference19 articles.
1. Global burden of COPD: risk factors, prevalence, and future trends;Mannino;Lancet,2007
2. Impact of preventing exacerbations on deterioration of health status in COPD;Spencer;Eur. Respir. J.,2004
3. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK;Brusselle;Int. J. Chronic Obstr. Pulm. Dis.,2015
4. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial;Singh;Lancet,2017
5. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial;Vestbo;Lancet,2017